Literature DB >> 18187085

Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection.

Olivier Morel1, Patrick Ohlmann, Eric Epailly, Babe Bakouboula, Fatiha Zobairi, Laurence Jesel, Nicolas Meyer, Marie-Pierre Chenard, Jean-Marie Freyssinet, Pierre Bareiss, Jean-Philippe Mazzucotelli, Florence Toti.   

Abstract

BACKGROUND: Circulating procoagulant microparticles are reliable markers of vascular damage. The microparticle phenotypes provide additional information reflecting the nature of cell injury. This study assessed procoagulant microparticle levels and phenotypes in the diagnosis of acute allograft rejection after heart transplantation.
METHODS: Microparticles were prospectively investigated in the venous blood of 64 heart transplant patients, 23 with allograft rejection mainly of low score, and 41 without a rejection episode. Plasma concentrations of cytokines, cytoadhesins, and platelet activation markers were determined.
RESULTS: By univariate analysis, the mean time elapsed from heart transplant, cold ischemia time, E-selectin-, Fas- and tissue factor-bearing microparticles were associated with allograft rejection. By multivariate analysis, E-selectin-microparticle levels appeared independently associated with allograft rejection, even when other significant variables were included in the model (odds ratio, 9.8; 95% confidence interval, 1.36-71.4; p = 0.023).
CONCLUSION: The pattern of procoagulant microparticles released during acute allograft rejection suggests endothelial cell activation and Fas-mediated apoptosis. E-selectin-bearing microparticles appeared as an independent marker of acute allograft rejection that was still informative after adjustment for graft characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187085     DOI: 10.1016/j.healun.2007.09.031

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  17 in total

Review 1.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

2.  Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection.

Authors:  Matthew T Rondina; Kohei Tatsumi; Julie A Bastarache; Nigel Mackman
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

Review 3.  Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.

Authors:  Olivier Morel; Nicolas Morel; Laurence Jesel; Jean-Marie Freyssinet; Florence Toti
Journal:  Semin Immunopathol       Date:  2011-08-25       Impact factor: 9.623

4.  Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population.

Authors:  Anne M Curtis; Lifeng Zhang; Elizabeth Medenilla; Ming Gui; Patrick F Wilkinson; Erding Hu; Jay Giri; Vijay Doraiswamy; Sampath Gunda; Mark E Burgert; Jonni S Moore; Jay M Edelberg; Emile R Mohler
Journal:  Cytometry B Clin Cytom       Date:  2010-06-11       Impact factor: 3.058

5.  Endothelial microparticles induce inflammation in acute lung injury.

Authors:  Keely L Buesing; John C Densmore; Sushma Kaul; Kirkwood A Pritchard; Jason A Jarzembowski; David M Gourlay; Keith T Oldham
Journal:  J Surg Res       Date:  2010-06-09       Impact factor: 2.192

6.  Circulating endothelial microparticles in diabetes mellitus.

Authors:  A F Tramontano; R Lyubarova; J Tsiakos; T Palaia; J R Deleon; L Ragolia
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

Review 7.  Endothelial microparticles: sophisticated vesicles modulating vascular function.

Authors:  Anne M Curtis; Jay Edelberg; Rebecca Jonas; Wade T Rogers; Jonni S Moore; Wajihuddin Syed; Emile R Mohler
Journal:  Vasc Med       Date:  2013-07-26       Impact factor: 3.239

8.  Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

Authors:  Iwijn De Vlaminck; Hannah A Valantine; Thomas M Snyder; Calvin Strehl; Garrett Cohen; Helen Luikart; Norma F Neff; Jennifer Okamoto; Daniel Bernstein; Dana Weisshaar; Stephen R Quake; Kiran K Khush
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

Review 9.  Clinical significance of procoagulant microparticles.

Authors:  Shosaku Nomura; Michiomi Shimizu
Journal:  J Intensive Care       Date:  2015-01-07

10.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.